News for hackers. Stuff that matters.
Re:Norepinephrine-mediated slow vasomotion drives glymphatic... by ajmurmann on Wednesday January 15, 2025 @10:45AM (#42712262)
Seems like this is an issue for the company that makes Ambien but an opportunity for everyone else in that industry (and for patients)

There are no comments on this comment yet.